Cutaneous adverse drug reaction: Prospective study of 118 cases;Profil des toxidermies médicamenteuses: Étude prospective de 118 cas

Tunisie Medicale

Volumn 91, Issue 8-9, 2013, Pages 514-520

  Chaabane, Hend ^a,b   Masmoudi, Abderrahmen ^a,b   Amouri, Meriem ^a,b   Ghorbel, Sonda ^a,b   Boudaya, Sonia ^a,b   Hammami, Serriya ^a,b   Zghal, Khaled ^a,b   Turki, Hamida ^a,b  

^a HEDI CHAKER HOSPITAL   (Tunisia)

^b UNIVERSITY OF SFAX   (Tunisia)

Author keywords

Adverse drug reactions; Antibiotics; Anticonvulsants; Maculopapular rash

Indexed keywords

ANALGESIC AGENT; ANTIBIOTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLIN DERIVATIVE;

ARTICLE; DRUG ERUPTION; HUMAN; INCIDENCE; MACULOPAPULAR RASH; MAJOR CLINICAL STUDY; PHOTOSENSITIVITY; PREVALENCE; PROSPECTIVE STUDY; SKIN MANIFESTATION; URTICARIA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANALGESICS; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DERMATITIS; FEMALE; HUMANS; INFANT; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 84884870234     PISSN: 00414131     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Roujeau J. C, Bonnetblanc J. M, Schmutz J. L, Crickx B. Iatrogénie. Diagnostic et prevention des toxidermies. Ann Dermatol Venereol 2002; 129: S163-9.
2. Gerson D, Sriganeshan V, Alexis J.B. Cutaneous drug eruptions: A 5-year experience. J Am Acad Dermatol 2008; 59: 995-9.
3. Bigby M. Rates of cutaneous reactions to drugs. Arch Dermatol 2001; 137: 765-70.
4. Hernández-Salazar A, Rosales SP, Rangel-Frausto S, Criollo E, Archer-Dubon C, Orozco-Topete R. Epidemiology of adverse cutaneous drug reactions. A prospective study in hospitalized patients. Arch Med Res 2006; 37:899-902.
5. Bousquet P. J, Demoly P. Une synthèse sur l'épidemiologie des hypersensibilités médicamenteuses. Revue Fr Allergol Immunol Clin 2005; 45: 626-32.
6. Fiszenson-Albala F, Auzerie V, Mahe E et al. A 6-month prospective survey of cutaneous drug reactions in a hospital setting. Br J Dermatol 2003; 149: 1018-22.
7. Van der Linden PD, Van der Lei J, Vlug AE, Stricker BH. Skin Reactions to Antibacterial Agents in General Practice. J Clin Epidemiol 1998; 51: 703-8.
8. Bachot N, Roujeau J.C. Imputabilité médicamenteuse en pratique dermatologique quotidienne. Ann Dermatol Venereol 2000; 127: 542-5.
9. Bégaud B, Evreux JC, Jouglard J, Lagier G. Imputabilité des effets inattendus ou toxiques des médicaments. Therapie 1985; 40: 111-8.
10. Haramburu F, Miremont-Salamé G, Macquin K. Effets indésirables des médicaments: définitions et imputabilité. Rev Rhum 2002; 69: 346-8
11. Souissi A, Fenniche S, Benmously R, Ben Jannet S, Marrak H, Mokhtar I. Etude des réactions cutanées aux médicaments dans un centre hospitalo-universitaire à Tunis. Tunis Med 2007; 85:1011-5.
12. Sharma V. K, Sethuraman G, Kumar B. Cutaneous adverse drug reactions: clinical pattern and causative agents-A six year series from Scandigarh, India. J Postgrad Med 2001; 47: 95-9.
13. Choon SE, Lai NM. An epidemiological and clinical analysis of cutaneous adverse drug reactions seen in a tertiary hospital in Johor, Malaysia. Indian J Dermatol Venereol Leprol 2012; 78: 734-9.
14. Allain H, Pibouin M, Bénéton C, Laudren A, Milon D, Chevrant-Breton J. Poursuite sur 18 mois d'une enquête de pharmacovigilance en dermatologie. Bilan méthodique à 30 mois. Therapie 1987; 42: 311-5.
15. Capuano A, Motola G, Russo F et al. Adverse drug events in two emergency departments in Naples, Italy: an observational study. Pharmacol Res 2004; 50:631-6.
16. Martin RM, Biswas PN, Freemantle SN, Pearce GL, Mann RD. Age and sex distribution of suspected adverse drug reactions to newly marketed drugs in general practice in England: analysis of 48 cohort studies. Br J Clin Pharmacol 1998; 46: 505-11.
17. Bonnetblanc J.M. Réactions cutanées aux médicaments chez l'enfant. Ann Dermatol Venereol 1997; 124: 339-45.
18. Bonnetblanc JM, Vaillant L, Wolkenstein P. Facteurs prédisposants des réactions cutanées aux médicaments. Ann Dermatol Venereol 1995;122:484-6.
19. Montastruc JL, Lapeyre-Mestre M, Bagheri H, Fooladi A. Gender differences in adverse drug reactions: analysis of spontaneous reports to a Regional Pharmacovigilance Centre in France. Fundam Clin Pharmacol 2002; 16: 343-6.
20. Naldi L, Conforti A, Venegoni M et al. Cutaneous reactions to drugs. An analysis of spontaneous reports in four Italian regions. Br J Clin Pharmacol 1999; 48: 839-46.
21. Rademaker M. Do women have more adverse drug reactions? Am J Clin Dermatol 2001; 2: 349-51.
22. Kharfi M, Masmoudi A, Bodemer C et al. Dermatite atopique: comparaison des prévalences en France et en Tunisie. Ann Dermatol Venereol 2005; 132:478-9.
23. Sánchez-Borges M, Capriles-Hulett A. Atopy is a risk factor for non-steroidal anti-inflammatory drug sensitivity. Ann Allergy Asthma Immunol 2000; 84: 101-6.
24. Renn CN, Straff W, Dorfmüller A, Al-Masaoudi T, Merk HF, Sachs B. Amoxicillin-induced exanthema in young adults with infectious mononucleosis: demonstration of drug-specific lymphocyte reactivity. Br J Dermatol 2002; 147:1166-70.
25. Saito-Katsuragi M, Asada H, Yokoi S, Niizeki H, Miyagawa S. Ampicillin-induced cutaneous eruption associated with Epstein-Barr virus reactivation. J Am Acad Dermatol 2005; 52 (Suppl 1), S127-8.
26. Beani JC. Les photodermatoses médicamenteuses: comment les diagnostiquer et les explorer? Rev Med Interne 1995; 16 (Suppl 3): 337s-341s.
27. Allen J.E. Drug-induced photosensitivity. Clin Pharm 1993; 12: 580-7.
28. Gould J. W, Mercurio M. G, Elmets C.A. Cutaneous photosensitivity diseases induced by exogenous agents. J Am Acad Dermatol 1995; 33: 551-73.
29. Murphy GM. Diseases associated with photosensitivity. J Photochem Photobiol B 2001; 64: 93-8.
30. Svensson CK, Cowen EW, Gaspari AA. Cutaneous drug reactions. Pharmacol Rev 2001; 53: 357-79.
31. Ozkaya-Bayazit E. Specific site involvement in fixed drug eruption. J Am Acad Dermatol 2003; 49:1003-7.
32. Mahboob A, Haroon TS. Drugs causing fixed eruptions: a study of 450 cases. Int J Dermatol 1998; 37: 833-8.
33. Bonnetblanc JM. Toxidermie. Ann Dermatol Venereol 2005; 132: 924-5.
34. Nussinovitch M, Prais D, Ben-Amitai D, Amir J, Volovitz B. Fixed drug eruption in the genital area in 15 boys. Pediatr Dermatol 2002; 19: 216-9.
35. Vaillant L, Berbis P, Chevrant-Breton J, Bonnetblanc JM. Prurit. Ann Dermatol Venereol 2002; 129(Suppl10): S213-8.
36. Lorette G, Vaillant L. Pruritus. Current concepts in pathogenesis and treatment. Drugs 1990; 39: 218-23.
37. Aquilina C, Sayag J. Eczémas par réactogènes internes. Ann Dermatol Venereol 1989; 116: 753-65.
38. Wolf R, Orion E, Marcos B, Matz H. Life-threatening acute adverse cutaneous drug reactions. Clin Dermatol 2005; 23: 171-81.
39. Roujeau JC, Stern RS. Severe adverse cutaneous reactions to drugs. N Engl J Med 1994; 331: 1272-85.
40. Kaufman DW, Kelly JP. Acetyl salicylic acid and other salicylates in relation to Stevens-Johnson syndrome and toxic epidermal necrolysis. Br J Clin Pharmacol 2001; 51: 174-6.
41. Roujeau JC, Kelly JP, Naldi L et al. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med 1995; 333: 1600-7.
42. Sharma V. K, Sethuraman G, Minz A. Stevens Johnson syndrome, toxic epidermal necrolysis and SJS-TEN overlap: A retrospective study of causative drugs and clinical outcome. Indian J Dermatol Venerol Leprol 2008; 74: 238-40.
43. Romaguera C, Grimalt F, Vilaplana J, Azon A. Erythroderma from carbamazepine. Contact Dermatitis 1989; 20:304-5.
44. Kamaliah MD, Zaimal D, Mokhtar N, Nazmi N. Erythema multiforme, Steven Johnson Syndrome and toxic epidermal necrolysis in North East Malaysia. Int J Dermatol 1998; 37: 520-3.
45. Bocquet H, Bagot M, Roujeau J.C. Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms: DRESS). Semin Cutan Med Surg 1996; 15: 250-7.
46. Gaig P, García-Ortega P, Baltasar M, Bartra J. Drug Neosensitization During Anticonvulsant Hypersensitivity Syndrome. J Investig Allergol Clin Immunol 2006; 16: 321-6.
47. Begon E., Roujeau J.C. Syndrome d'hypersensibilité médicamenteuse ou DRESS. Ann Dermatol Venereol 2004; 131: 293-7.
48. Gupta A, Eggo MC, Uetrecht JP et al. Drug-induced hypothyroidism: the thyroid as a target organ in hypersensitivity reactions to anticonvulsants and sulfonamides. Clin Pharmacol Ther 1992; 51: 56-67.
49. Hanjani NM, Rencic A, Whitmore SE. Pityriasis rosea-like eruption due to bismuth. Cutis 2006; 77: 166-8.
50. Atzori L, Pinna AL, Ferreli C, Aste N. Pityriasis rosea-like adverse reaction: review of the literature and experience of an Italian drug-surveillance center. Dermatol Online J 2006; 12: 1.